Patent · US Expired

Pharmaceutic formulation for the treatment of alcoholism

US5519017A · kind A · utility

11Cited by

5References

9Claims

0Family size

Assignees

LTS Lohmann Therapie-Systeme GmbH Co. KG · DE
Hefa-Frenon Arzneimittel GmbH & Co. KG · DE

Inventor

Klaus Opitz · Münster, DE

Key dates

Filing date	May 5, 1994
Grant date	May 21, 1996
Priority date	—
Expiry date	May 5, 2014

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/7084
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Galanthamine and the pharmaceutically suitable acid addition salts thereof can be used for the treatment of alcoholism; these compounds are released from adequate pharmaceutic formulations which are administered, e.g., orally, transdermally, or otherwise parenterally, in a continuous and controlled manner.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.